A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International Journal of Molecular Sciences 22.19 (2021): 10227.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2021
- Creator
-
Bosch, Naomi C.
Martin, Lena-Marie
Voskens, Caroline J.
Berking, Carola
Seliger, Barbara
Schuler, Gerold
Schaft, Niels
Dörrie, Jan
- DOI
-
10.3390/ijms221910227
- URN
-
urn:nbn:de:bvb:29-opus4-195174
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bosch, Naomi C.
- Martin, Lena-Marie
- Voskens, Caroline J.
- Berking, Carola
- Seliger, Barbara
- Schuler, Gerold
- Schaft, Niels
- Dörrie, Jan
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2021
Other Objects (12)
Engineering designer dendritic cells to activate natural killer cells
Chimeric toxins for specific targeting of cancer cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
CX3CR1+ antigen presenting cells of the lamina propria activate CD4 T cells during transfer colitis
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
NFK
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
Engineering designer dendritic cells to activate natural killer cells
Chimeric toxins for specific targeting of cancer cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
CX3CR1+ antigen presenting cells of the lamina propria activate CD4 T cells during transfer colitis
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
NFK
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
Engineering designer dendritic cells to activate natural killer cells
Chimeric toxins for specific targeting of cancer cells
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric Antigen Receptor T Cell Research For Clinical Applications
Chimeric antigen receptor T cells for acute myeloid leukemia
Targeting and Elimination of T Cell Subpopulations by Chimeric Antigen Receptor-modified T Cells
CX3CR1+ antigen presenting cells of the lamina propria activate CD4 T cells during transfer colitis
Chimeric antigen receptor T cell therapy to target lymphoid neoplasms
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
NFK